An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma Article

Chakravarti, A, Berkey, B, Robins, HI et al. (2006). An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma . JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 1527-1527. 10.1200/jco.2006.24.18_suppl.1527

cited authors

  • Chakravarti, A; Berkey, B; Robins, HI; Guha, A; Curran, WJ; Brachman, D; Shultz, C; Mehta, M

authors

publication date

  • June 20, 2006

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Orphan Drug
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 1527

end page

  • 1527

volume

  • 24

issue

  • 18_suppl